RODGERS RICHARD J 1313397 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-16 | 2023-06-15 | 2023-06-15 | 4 | Rodgers Richard J | DIRECTOR | acq | 18494.0 | 7.76 | 0.86 | 0.0 | Direct | Common Stock | ARDELYX, INC. | code A | 238320.0 | 214.46 (ARDX) |
| 2023-10-31 | 2023-10-29 | 2023-10-29 | 4 | Rodgers Richard J | DIRECTOR | acq | 3800.0 | 100.0 | 0.4 | 0.0 | Direct | Common Stock | NOVAVAX INC | code M | 3800.0 | 94.4 (NVAX) |
| 2023-11-13 | 2023-11-01 | 2023-11-01 | 4 | Rodgers Richard J | DIRECTOR | acq | 35000.0 | 20.2 | 16.66 | 0.0 | Direct | Common Stock | OCUPHIRE PHARMA, INC. | code A | 173246.0 | 21.01 (OCUP) |
| 2024-01-03 | 2024-01-01 | 2024-01-01 | 4 | Rodgers Richard J | DIRECTOR | acq | 24762.0 | 12.51 | 10.94 | 0.0 | Direct | Common Stock | OCUPHIRE PHARMA, INC. | code A | 198008.0 | 22.64 (OCUP) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-13 | 2023-06-12 | 2023-06-12 | 4 | Rodgers Richard J | DIRECTOR | acq | 7710.0 | 100.0 | 0.89 | 7.78 | Direct | Stock Option (Right To Buy) | NOVAVAX INC | code A | 7710.0 | 86.31 (NVAX) |
| 2023-06-13 | 2023-06-12 | 2023-06-12 | 4 | Rodgers Richard J | DIRECTOR | acq | 6670.0 | 100.0 | 0.77 | 0.0 | Direct | Restricted Stock Units | NOVAVAX INC | code A | 6670.0 | 86.31 (NVAX) |
| 2023-06-16 | 2023-06-15 | 2023-06-15 | 4 | Rodgers Richard J | DIRECTOR | acq | 49237.0 | 100.0 | 2.3 | 3.92 | Direct | Stock Option (Right To Buy) | ARDELYX, INC. | code A | 49237.0 | 214.46 (ARDX) |
| 2023-07-13 | 2023-07-13 | 3 | Rodgers Richard J | DIRECTOR | holding | 49031.0
|
0 | 7.03 | Direct | Stock Option (Right To Buy) | SAGIMET BIOSCIENCES INC. | NA | 0.0 (SGMT) | |||
| 2023-07-20 | 2023-07-18 | 2023-07-18 | 4 | Rodgers Richard J | DIRECTOR | dsp | 49031.0 | 100.0 | 7.03 | Direct | Stock Option (Right To Buy) | SAGIMET BIOSCIENCES INC. | code D | 0.0
|
0.0 (SGMT) | |
| 2023-07-20 | 2023-07-18 | 2023-07-18 | 4 | Rodgers Richard J | DIRECTOR | acq | 49031.0 | 100 | 7.03 | Direct | Stock Option (Right To Buy) | SAGIMET BIOSCIENCES INC. | code A | 23839.0
|
0.0 (SGMT) | |
| 2023-10-31 | 2023-10-29 | 2023-10-29 | 4 | Rodgers Richard J | DIRECTOR | dsp | 3800.0 | 33.33 | 0.4 | 0.0 | Direct | Restricted Stock Units | NOVAVAX INC | code M | 7600.0 | 94.4 (NVAX) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)